LGC COVID-19 antibody assay processes up to 40,000 tests per day in UK

News (ZH) - First commercially cvailable SARS-CoV-2 antibody test in UK compatible with Neoteryx’s Mitra® Microsampling Device for at-home blood collection

LGC announces new senior appointments

News (ZH) - LGC has announced three new senior appointments

Measurement for Recovery (M4R) launched to boost UK innovation

News (ZH) - M4R will run until the end of 2020 and will enable businesses to have access to the world-leading chemical and bio-measurement expertise and capabilities at the NML.

LGC and Aptahem combine on first large-scale production campaign of Apta-1

News (ZH) - First large-scale production run of Apta-1as a non-GMP material, intended for use in GLP toxicology studies

Kent consortium gets green light to develop £60million investment bid: proposal to accelerate medicines development via data and digital technology

News (ZH) - A proposal that could bring £60million investment into the life sciences sector in Kent has taken a significant stride forward by securing £50,000 to develop the bid further. The money is seedcorn funding via UK Research and Innovation’s flagship £236m Strength in Places Fund.

LGC SeraCare SARS-CoV-2 Molecular Controls Kit now CE-Marked

News (ZH) - Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2 Molecular Controls Kit meets extensive design control requirements

LGC expands SARS-CoV-2 molecular solutions to full genome coverage

News (ZH) - Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

News (ZH) - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma 

NML response to the Research and Development Roadmap

News (ZH) - The National Measurement Laboratory (NML), hosted at LGC, welcomes the publication of the UK government’s Research and Development (R&D) Roadmap with its ongoing commitment to increased investment in R&D to cement the UK’s world-leading position within science and research and support the individuals behind it

LGC and Q2 Solutions announce global bioanalytical strategic partnership

News (ZH) - Will each contribute extensive experience and capabilities in small and large molecule bioanalysis to support customer-centric approach